Healthcare provider profile · identity verified

Paul Edward Perryman, MD

Internal Medicine · COLUMBIA, TN · NPI 1851384747

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	882	235
Amlodipine Besylate	Amlodipine Besylate	392	109
Losartan Potassium	Losartan Potassium	384	114
Omeprazole	Omeprazole	383	116
Levothyroxine Sodium	Levothyroxine Sodium	309	77
Rosuvastatin Calcium	Rosuvastatin Calcium	297	90
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	263	71
Lisinopril	Lisinopril	201	63
Allopurinol	Allopurinol	167	42
Jardiance	Empagliflozin	154	33
Sertraline Hcl	Sertraline Hcl	150	37
Ezetimibe	Ezetimibe	142	43
Spironolactone	Spironolactone	136	42
Tamsulosin Hcl	Tamsulosin Hcl	136	43
Metoprolol Succinate	Metoprolol Succinate	132	37
Metformin Hcl Er	Metformin Hcl	129	36
Pantoprazole Sodium	Pantoprazole Sodium	125	36
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	122	37
Gabapentin	Gabapentin	120	36
Ozempic	Semaglutide	116	28
Metformin Hcl	Metformin Hcl	111	33
Escitalopram Oxalate	Escitalopram Oxalate	104	29
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	104	27
Furosemide	Furosemide	102	25
Metoprolol Tartrate	Metoprolol Tartrate	101	29
Hydrochlorothiazide	Hydrochlorothiazide	94	33
Glipizide	Glipizide	91	22
Alendronate Sodium	Alendronate Sodium	86	30
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	83	22
Prednisone	Prednisone	72	39
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	70	27
Bupropion Xl	Bupropion Hcl	68	11
Carvedilol	Carvedilol	68	19
Simvastatin	Simvastatin	64	19
Pravastatin Sodium	Pravastatin Sodium	63	17
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	62	47
Eliquis	Apixaban	56	16
Finasteride	Finasteride	56	14
Mirtazapine	Mirtazapine	54	13
Fluoxetine Hcl	Fluoxetine Hcl	53	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	52	14
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	51	12
Quetiapine Fumarate	Quetiapine Fumarate	51	14
Torsemide	Torsemide	51	11
Fluticasone Propionate	Fluticasone Propionate	50	23
Potassium Chloride	Potassium Chloride	50	15
Trulicity	Dulaglutide	46	suppressed
Cephalexin	Cephalexin	41	36
Irbesartan	Irbesartan	39	11
Albuterol Sulfate Hfa	Albuterol Sulfate	38	25
Felodipine Er	Felodipine	38	suppressed
Nebivolol Hcl	Nebivolol Hcl	38	12
Trazodone Hcl	Trazodone Hcl	37	12
Valacyclovir	Valacyclovir Hcl	37	19
Lovastatin	Lovastatin	35	suppressed
Valsartan	Valsartan	35	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	11
Xarelto	Rivaroxaban	33	suppressed
Mounjaro	Tirzepatide	32	suppressed
Estradiol	Estradiol	31	11
Buspirone Hcl	Buspirone Hcl	29	11
Clopidogrel	Clopidogrel Bisulfate	28	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	28	suppressed
Farxiga	Dapagliflozin Propanediol	28	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Synthroid	Levothyroxine Sodium	26	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	25	24
Atenolol	Atenolol	24	suppressed
Cefuroxime	Cefuroxime Axetil	24	18
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	24	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	23	suppressed
Duloxetine Hcl	Duloxetine Hcl	21	suppressed
Primidone	Primidone	21	suppressed
Propranolol Hcl Er	Propranolol Hcl	21	suppressed
Ipratropium Bromide	Ipratropium Bromide	20	suppressed
Novolog Flexpen	Insulin Aspart	20	suppressed
Tramadol Hcl	Tramadol Hcl	20	suppressed
Meloxicam	Meloxicam	19	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	15
Terazosin Hcl	Terazosin Hcl	19	suppressed
Amiloride-Hydrochlorothiazide	Amiloride/Hydrochlorothiazide	18	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	18	suppressed
Eplerenone	Eplerenone	18	suppressed
Citalopram Hbr	Citalopram Hydrobromide	17	suppressed
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	15
Warfarin Sodium	Warfarin Sodium	16	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	15	suppressed
Glimepiride	Glimepiride	15	suppressed
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Januvia	Sitagliptin Phosphate	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Methenamine Hippurate	Methenamine Hippurate	13	suppressed
Nitroglycerin Patch	Nitroglycerin	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Candesartan-Hydrochlorothiazid	Candesartan/Hydrochlorothiazid	12	suppressed
Evenity (2 Syringes)	Romosozumab-Aqqg	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Montelukast Sodium	Montelukast Sodium	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	12
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Celecoxib	Celecoxib	11	suppressed
Clonazepam	Clonazepam	11	suppressed
Dutasteride	Dutasteride	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Premarin	Estrogens, Conjugated	11	suppressed
Repatha Sureclick	Evolocumab	11	suppressed
Rivastigmine	Rivastigmine	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error